Skip to content

Premature Family Music Therapy Intervention (PFMI)

Premature Family Music Therapy Intervention (PFMI): an Italian Protocol to Support Parenting, Attachment Bond and Preterm Development

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04335240
Acronym
PFMI
Enrollment
90
Registered
2020-04-06
Start date
2021-04-30
Completion date
2022-12-01
Last updated
2022-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Music Therapy

Keywords

Music therapy, NICU, Preterm, Infants, Music, HRV, Neurodevelopment

Brief summary

The music therapy intervention it is dedicated to premature baby and their family at the Neonatal Intensive Care Unit (NICU)of the Woman-Child department Hospital Del Ponte. In NICU an integrated psychological and music therapeutic protocol has been structured. The protocol aims to limit or overcome long-term developmental morbidities, promote parenting and attachment bond in preterm infants. Protocol is named Premature family music therapy intervention (PFMI): an Italian protocol to support parenting, attachment bond and preterm development. The methodologies will provide early intervention from the first days of hospitalization in NICU and use music therapy sessions active (chant parental, live music and lullaby) and receptive (listening to recorded tracks). Such therapy becomes a support for the born prematurely and her parents during hospitalization and after discharge. The music therapy accompanies the newborn and his parents during the hospitalization and focuses its attention on the emotional-relational care, according to the different needs of babies and parents. This protocol it is a Family Centered Care Music Therapy Intervention.

Detailed description

All infants will be enrolled when in stable clinical condition within two weeks after birth. Therapy sessions will take place minimum three times per week on three different days of the week directly at the unit during the entire hospitalization until discharge. After discharge music therapy treatment will be performed once a week until twelve months of corrected age. The infant's wellbeing and relaxation during each session of music therapy will be measured using the following parameters: HRV (Heart Rate Variability) analysis Oxygen's saturation Stress level of the child Infants will be followed till 12 months of corrected age. Investigators will assess: Neuro-behavioral and neurological development of the child Stress level of the parents

Interventions

OTHERPremature family music therapy intervention to support parenting, attachment bond and preterm development

We have structured an integrated psychological and music therapeutic protocol that aims to limit or overcome neonatal long-term developmental morbidities, promote parenting and attachment bond in preterm infants.

Sponsors

Ospedale di Circolo - Fondazione Macchi
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

A prospective randomized controlled trial will be conducted. Infants will be divided in two subgroups: an intervention group (that will undergo music therapy treatment) and a control group. To evaluate the effectiveness of the protocol, the effects of treatment in the short- and long-term period will be evaluated, with particular reference to the clinical course, the neuro-behavioral development of the premature baby and the relationship with his parents.

Intervention model description

Prospective randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
23 Weeks to 12 Months
Healthy volunteers
Yes

Inclusion criteria

, Preterm infants born, will be eligible for the study, if they will be: 1. Born between 22+6- and 32-weeks postmenstrual age 2. Weight less than 1500 g 3. Free from major congenital defects 4. Free from cerebral and/or intraventricular hemorrhage 5. Singleton or twin gestation 6. No sensorineural hearing loss (at discharge, passed bilateral hearing screening) 7. Free from Necrotizing enterocolitis 8. Free from severe retinopathy 9. No asphyxiated 11\. No terms of surgical relevance 12. Born from HIV negative and drug free mothers

Exclusion criteria

, we will exclude infants whose mothers will be: 1. Affected by drug dependence 2. Affected by psychosis or other severe mental health problems 3. Unable to adequately speak/understand Italian language 4. Younger than 18 years of age 5. Physically unable to participate

Design outcomes

Primary

MeasureTime frameDescription
HRV analysisthrough test completion, starting from 5 minutes before the test until 5 minutes after test endedThe heart rate variability is related to the interaction of the sympathetic nervous system (alarm system) and parasympathetic (vagal). HRV derives from the balance of Low Frequency (LF) and High Frequency (HF). LF parameter represents the Sympathetic System and is correlated to a state of stress, while HF parameter represents the Parasympathetic System and is correlated to a state of relaxation. The balance of the two parameters (represented by value 1), means that their relationship is a state of well-being.
Oxygen's saturationthrough test completion, starting from 5 minutes before the test until 5 minutes after test endedMonitor oxygen saturation by medical monitor in Neonatal Intensive Care and Neonatology.

Secondary

MeasureTime frameDescription
Stress level of the parentsat 6 and 12 months of corrected ageParenting Stress Index-Short Form (PSI-SF, Abidin, 1995; Italian version edited by Guarino et al., 2007) at 6-12 months of corrected age State-Trait Anxiety Scale (STAI; Spielberger, 1983; Italian validation of Pedrabissi and Santinello (1996) at 6-12 months of corrected age Beck Depression Inventory (BDI, Beck, 1967) at 6-12 months of corrected age
Neuro-behavioral and neurological development of the childat 6-12 months of corrected ageTemperament detected by the test QUIT (Italian Questionnaires of Temperament Axia, 2002)

Countries

Italy

Contacts

Primary ContactBarbara S Sgobbi, MA
barbarasgobbi@gmail.com+390332299421
Backup ContactLaura S Morlacchi, MD
laura.morlacchi@asst-settelaghi.it+390332299420

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026